3,000 cancer patients to help unlock secrets of drug resistance
NCT ID NCT03572192
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to collect tissue and blood samples from 3,000 adults with solid tumors to learn why cancers spread and become resistant to treatments. Researchers will use advanced lab tests to find molecular defects that drive cancer growth. The goal is to use this knowledge to develop better treatments and tests in the future. Participants will donate samples taken during routine medical procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St Bartholomew's Hospital
RECRUITINGLondon, EC1A 7BE, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a Tumor's DNA guide better cancer care for kids?
- Can a new PET tracer reveal a key cancer target?
- Can a smart drug home in on Hard-to-Treat cancers?
- Can a new tracer light up cancer growth?
- Can a Dual-Pronged antibody outsmart advanced cancers?